Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) was the recipient of a significant increase in short interest in June. As of June 15th, there was short interest totaling 172,800 shares, an increase of 392.3% from the May 31st total of 35,100 shares. Based on an average trading volume of 51 shares, the days-to-cover ratio is currently 3,388.2 days.
Ascentage Pharma Group International Stock Performance
Shares of ASPHF opened at $4.53 on Monday. The business’s fifty day moving average is $6.17 and its 200 day moving average is $7.67. Ascentage Pharma Group International has a 12-month low of $4.53 and a 12-month high of $5.05.
About Ascentage Pharma Group International
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
